Outlook Therapeutics (OTLK)'s 30-day implied volatility (IV30) was 121.8% at the close on October 23, 2026, down from 126.0% the day before, against a 52-week range of 77.4% to 392.6%. Its 20-day historical volatility was 105.8%.
Data as of October 23, 2026.